Open | $1.450 |
Close | $1.440 |
Volume / Avg. | 7.972M / 13.270M |
Day Range | 1.370 - 1.545 |
52 Wk Range | 0.879 - 5.530 |
Market Cap | $285.258M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 15.84% |
Days to Cover | 3.42 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of bluebird bio (NASDAQ: BLUE) through any online brokerage.
Other companies in bluebird bio’s space includes: Inovio Pharmaceuticals (NASDAQ:INO), Gritstone Bio (NASDAQ:GRTS), Mesoblast (NASDAQ:MESO), Opthea (NASDAQ:OPT) and RAPT Therapeutics (NASDAQ:RAPT).
The latest price target for bluebird bio (NASDAQ: BLUE) was reported by HSBC on Tuesday, March 5, 2024. The analyst firm set a price target for 1.02 expecting BLUE to fall to within 12 months (a possible -31.08% downside). 16 analyst firms have reported ratings in the last year.
The stock price for bluebird bio (NASDAQ: BLUE) is $1.48 last updated March 18, 2024 at 7:59 PM EDT.
There are no upcoming dividends for bluebird bio.
bluebird bio’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for bluebird bio.
bluebird bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.